Leveraging Foreign Clinical Data Extrapolation to Accelerate Global Drug Development: A Case Study in Hematological Oncology

2021 ◽  
pp. 129-135
Author(s):  
Hongjie Zhu ◽  
Jingjing Ye ◽  
Xiang Guo
Author(s):  
Houssam Nassif ◽  
Ryan Woods ◽  
Elizabeth Burnside ◽  
Mehmet Ayvaci ◽  
Jude Shavlik ◽  
...  

Author(s):  
Manu Venugopal

The drug development phase is one of the most time-consuming and expensive stages in the lifecycle of a drug. Marred by patent expirations, price regulations, complexities in disease conditions, life sciences companies are facing a daunting task to bring new molecular entities into the market. Digital health technologies are playing a critical role in addressing some of the challenges faced during drug development. In this chapter, the author talks about the challenges and key trends in the world of drug development, use of new digital health technologies, and the future of drug development. As an example, the author dives into a specific case study on the use of virtual assistants in clinical trials and the benefits of its usage on patients, healthcare professionals, and life sciences companies.


Sign in / Sign up

Export Citation Format

Share Document